Two Sigma Advisers’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.5M | Sell |
846,900
-2,057,000
| -71% | -$74.1M | 0.06% | 259 |
|
|
2025
Q1 | $90.4M | Sell |
2,903,900
-769,300
| -21% | -$23.9M | 0.2% | 103 |
|
|
2024
Q4 | $93.7M | Buy |
3,673,200
+640,000
| +21% | +$16.3M | 0.22% | 86 |
|
|
2024
Q3 | $85.8M | Buy |
3,033,200
+936,900
| +45% | +$26.5M | 0.2% | 101 |
|
|
2024
Q2 | $55.3M | Buy |
2,096,300
+573,900
| +38% | +$15.1M | 0.12% | 156 |
|
|
2024
Q1 | $46.2M | Sell |
1,522,400
-478,700
| -24% | -$14.5M | 0.11% | 192 |
|
|
2023
Q4 | $56.2M | Buy |
2,001,100
+1,800
| +0.1% | +$50.6K | 0.13% | 167 |
|
|
2023
Q3 | $54.3M | Buy |
1,999,300
+1,051,700
| +111% | +$28.5M | 0.14% | 150 |
|
|
2023
Q2 | $29.1M | Buy |
947,600
+631,000
| +199% | +$19.4M | 0.07% | 240 |
|
|
2023
Q1 | $11.4M | Sell |
316,600
-271,100
| -46% | -$9.77M | 0.03% | 512 |
|
|
2022
Q4 | $23.2M | Sell |
587,700
-121,100
| -17% | -$4.79M | 0.06% | 298 |
|
|
2022
Q3 | $28.5M | Sell |
708,800
-43,200
| -6% | -$1.74M | 0.08% | 243 |
|
|
2022
Q2 | $31.6M | Buy |
752,000
+344,600
| +85% | +$14.5M | 0.09% | 237 |
|
|
2022
Q1 | $15.9M | Buy |
407,400
+133,400
| +49% | +$5.2M | 0.04% | 378 |
|
|
2021
Q4 | $10.9M | Buy |
274,000
+176,800
| +182% | +$7.05M | 0.03% | 483 |
|
|
2021
Q3 | $3.51M | Buy |
+97,200
| New | +$3.51M | 0.01% | 956 |
|